Is MIRA Pharmaceuticals, Inc. Common Stock (MIRA) overvalued? · $41.1M cap
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a drug manufacturers - general company listed on NASDAQ.
This page asks whether MIRA Pharmaceuticals, Inc. Common Stock (MIRA) looks expensive on cached numbers — not a short thesis.
No cached income statement for MIRA, so there is no earnings base to call rich or cheap.
MIRA currently screens at market cap $41.1M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MIRA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MIRA stock page for the full model, not this heading.
Not investment advice.